Cmpx stock forecast.
The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecasts
FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22. Total current assets stand at $120.231 million, much more than the total amount of liabilities. With notes receivable worth $18.7 million and goodwill of $23.742 million, CompX reported total ...The average one-year price target for CMPX / Compass Therapeutics Inc is $9.35. The forecasts range from a low of $8.08 to a high of $11.55. A stock’s price target is the price at which analysts consider it fairly valued with respect to …View the latest CMPX earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Stock Ideas and …The 6 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving stock ratings to CMPX in the past 3 months.
CMPX Stock Price Chart Interactive Chart > Compass Therapeutics Inc. (CMPX) Company Bio. Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel …Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days.
View the full NASDAQ Composite Index (COMP.US) index overview including the latest stock market news, data and trading information.Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business.
PSTX Stock 12 Months Forecast. $12.25. (369.35% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Poseida Therapeutics in the last 3 months. The average price target is $12.25 with a high forecast of $15.00 and a low forecast of $8.00. The average price target represents a 369.35% change from the last price of $2.61.Jul 30, 2021 · In many cases to predict stock price, gold and crude oil have been used as extra indicators [36], in some of the works, 43 technical indicators as input features along with LSTM to forecast price ... US Stock MarketDetailed Quotes. PEPG PepGen. Close 11/13 16:00 ET. 4.340. +0.480 +12.44%. High 4.762 ... Inc. (PEPG), 4D Molecular Therapeutics (FDMT) and ...Nov 24, 2023 · The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...
Compass Therapeutics, Inc. - Hold. Zacks' proprietary data indicates that Compass Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CMPX shares ...
The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.
To get a sense of who is truly in control of Compass Therapeutics, Inc. (NASDAQ:CMPX), it is important to understand the ownership structure of the business. The group holding the most number of ...According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.Analyst Future Growth Forecasts. Earnings vs Savings Rate: CMPX is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CMPX is …Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as …Stock analysis for CompX International Inc (CIX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.
Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions. The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ...Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.FORECASTS Analyst Sentiment LeaderboardSOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ... CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.
From AI system, total return is 2366.52% from 4098 forecasts. For CompX International stock forecast for 2023, 1 predictions are offered for each month of 2023 with average CompX International stock forecast of $20.52, a high forec
March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.Compass Therapeutics, Inc. Common Stock (CMPX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.CMPX : 3.36 (+8.74%) Compass Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update Globe Newswire - Mon Mar 21, 2022. Ended 2021 with $144.5 million in cash and cash equivalentsCTX-009 (DLL4 X VEGF-A bispecific antibody) Global Phase 2 study in patients with advanced... See the latest Compass Therapeutics Inc Ordinary Shares stock price (NASDAQ:CMPX), related news, valuation, dividends and more to help you make your investing decisions.Previous Close $3.68. Volume 32.29K. Average Volume (3M) 157.25K. Market Cap. $1.22B. Enterprise Value $963.30M. Total Cash (Recent Filing) $259.49M. Total Debt (Recent Filing) $921.00K. Price to Earnings (P/E) -5.0.According to our current CMPX stock forecast, the value of Compass Therapeutics shares will drop by -2.77% and reach $ 1.497361 per share by November 19, 2023. According to …The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77 SCYX Stock 12 Months Forecast. $11.25. (555.98% Upside) Based on 3 Wall Street analysts offering 12 month price targets for SCYNEXIS in the last 3 months. The average price target is $11.25 with a high forecast of $15.00 and a low forecast of $7.50. The average price target represents a 555.98% change from the last price of $1.71.GTHX Stock 12 Months Forecast. $9.00. (429.41% Upside) Based on 3 Wall Street analysts offering 12 month price targets for G1 Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 429.41% change from the last price of $1.70.Nov 8, 2023 · Predictions of CMPX stock price for tomorrow.
Ford pegged the cost of the six-week UAW strikes at $1.7 billion, more than rival GM's $1.1 billion estimate, while issuing an updated 2023 profit forecast. STOCKS CRM
Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days.
View the latest Compass Therapeutics Inc. (CMPX) stock price, news, historical charts, analyst ratings and financial information from WSJ.FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22.Jul 11, 2023 · CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023. Prev Close 2.81. 52 Week High 5.65. 52 Week High Date 12/23/22. 52 Week Low 1.30. 52 Week Low Date 05/04/22. Market Cap 380.788M. Shares Out 126.51M. 10 Day Average Volume 0.28M. Dividend -.The average Albemarle stock price prediction forecasts a potential upside of 66.63% from the current ALB share price of $121.27. What is ALB's forecast return on equity (ROE) for 2023-2026? (NYSE: ALB) forecast ROE is N/A, which is considered weak.Compound Price Live Data. The live Compound price today is $51.45 USD with a 24-hour trading volume of $77,211,369 USD. We update our COMP to USD price in real-time. Compound is up 1.11% in the last 24 hours. The current CoinMarketCap ranking is #107, with a live market cap of $412,787,173 USD. It has a circulating supply of 8,023,528 …WVE. Wave Life Sciences Ltd. 5.31. -0.09. -1.67%. In this article, we will take a look at the 11 best biotech penny stocks to buy now. To see more such companies, go directly to 5 Best Biotech ...Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.
PAYO Stock 12 Months Forecast. $8.80. (56.58% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Payoneer in the last 3 months. The average price target is $8.80 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 56.58% change from the last price of $5.62.Find the latest ProShares UltraPro Short QQQ (SQQQ) stock quote, history, news and other vital information to help you with your stock trading and investing.Iterum Therapeutics plc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...Instagram:https://instagram. fe battery metalsdoes dental insurance cover crownsex dividend dates coming upbest futures markets to trade After a massive correction of 61% YTD, CMPX stock looks deeply undervalued and is poised for a strong reversal rally. As an overview, Compass is a clinical-stage oncology-focused company that’s ... crowns covered by dental insurancebest oil stocks to buy now Nov 24, 2023 · View Compass Therapeutics, Inc CMPX investment & stock information. Get the latest Compass Therapeutics, Inc CMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ... lincoln 2009 penny Track Compass Therapeutics Inc (CMPX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMost recent stock forecast was given on BGNE, BeiGene, Ltd at 26-Jun-2023 ... CMPX GLUE TNGX TPTX Turning Point Therapeutics NRIX Nurix Therapeutics COGT ...Aeterna Zentaris (TSE:AEZS) Forecast: Is this specialty biopharmaceutical company a good stock to buy? Find out the latest analysis, ratings, and price targets from TipRanks, the leading platform for financial insights.